DMD and cardiomyopathy: Despite its low prevalence (<3/10,000), dystrophin-associated cardiomyopathy is the form of DCM that has been modeled in vitro more extensively using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) from patients.